North America Rapid Test Kit Market Forecast to 2030

North America Rapid Test Kit Market Forecast to 2030

North America Rapid Test Kit Market Forecast to 2030 – Regional Analysis – by Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), and End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others)

Send Enquiry
Item ID: BMIRE00030521 Category: Tag:

$2,485 – $3,885

Description

The North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030; it is estimated to record a CAGR of 5.4% from 2022 to 2030.

Rising Prevalence of Genetic and Infectious Diseases Fuels North America Rapid Test Kit Market

A 2022 report by MJH Life Sciences (US) estimates that 300,000 newborns worldwide are born with sickle cell disease every year. According to the CDC, 1 in 500 African Americans is affected by sickle cell disease. The latest World Malaria Report (WMR) 2022 from the World Health Organization (WHO) states that nearly 247 million new malaria cases were reported in the world in 2021, in comparison to 245 million cases that were logged in 2020. According to the same source, the number of deaths caused due to malaria was 619,000 in 2021.

Sickle SCAN is a rapid test for the identification of sickle cell anemia with high sensitivity and specificity. Rapid diagnostic tests (RDTs) help diagnose malaria by detecting the presence of malarial parasites in human blood. Where access to high-quality microscopy services is limited, radiological diagnosis techniques are used as an alternative for clinical or microscope-based diagnosis. The COVID-19 pandemic had a significant impact on the rapid test kits market. Nearly all diagnostic tests used real-time PCR for testing people who showed symptoms of SARS-CoV-2 infection. Rapid test kits are nearly ubiquitous, robust, and reliable. Rapid testing techniques that involve the amplification of specific stretches of DNA for genotyping, cloning, and single nucleotide variation analysis are used in most molecular biology labs. Thus, the increasing incidence of genetic and infectious diseases propels the growth of the rapid test kits market.

North America Rapid Test Kit Market Overview

The rapid adoption of gene synthesis and editing tools such as CRISPR and PCR in research and therapeutics necessitates assays that are helpful in terms of rapid quantification, alterations, and observation. The US, seeking significant funding from public and private organizations, is expected to invest significantly in advanced research methodologies and is expected to be in the leading position in the rapid test kits market. There was a rapid increase in at-home test use occurred between the SARS-CoV-2 Delta- and Omicron-predominant periods of the pandemic. According to the CDC, in April 2023, more than 70 million test kits were shipped across the US.

North America Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

North America Rapid Test Kit Market Segmentation

The North America rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the North America rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the North America rapid test kit market is segmented into the US, Canada, and Mexico. The US dominated the North America rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the North America rapid test kit market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 5.4% CAGR, North America Rapid Test Kit Market is Speculated to be Worth US$ 10,462.82 Million by 2030, says the Research Team

According to the Research Team’ research, the North America rapid test kit market was valued at US$ 6,869.40 million in 2022 and is expected to reach US$ 10,462.82 million by 2030, registering a CAGR of 5.4% from 2022 to 2030. Innovations in rapid antigen tests and increasing preference for PCR techniques are among the critical factors attributed to the North America rapid test kit market expansion.

Operations of multiplex rapid antigen tests are based on multicolored nanoparticles and cross-reactive antibodies, and these test kits can be developed at low costs. When various respiratory pathogens are circulating simultaneously in a host body, rapid multiplex diagnostic testing helps healthcare providers supervise their patients with greater effectiveness. These tests can help avoid misdiagnosis that is possible due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, they help healthcare providers make apt decisions about the commencement and discontinuation of antimicrobial therapies. Compared to single specimen antigen tests kits, multiplex rapid antigen tests kits can detect many respiratory viruses from a single specimen, without compromising on the quality of results. Thus, innovations such as multiplex rapid antigen tests are emerging as future trends in the rapid test kits market.

On the contrary, uncertainties related to accuracy of results hamper the growth of North America rapid test kit market.

Based on type, the North America rapid test kit market is categorized into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held 64.0% market share in 2022, amassing US$ 4,398.96 million. It is projected to garner US$ 7,098.34 million by 2030 to register 6.2% CAGR during 2022-2030.

In terms of product, the North America rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held 62.0% share of North America rapid test kit market in 2022, amassing US$ 4,258.15 million. It is projected to garner US$ 6,707.13 million by 2030 to expand at 5.8% CAGR during 2022-2030.

By technology, the North America rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held 45.0% share of North America rapid test kit market in 2022, amassing US$ 3,091.17 million. It is projected to garner US$ 4,892.43 million by 2030 to expand at 5.9% CAGR during 2022-2030.

In terms of application, the North America rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held 55.0% share of North America rapid test kit market in 2022, amassing US$ 3,779.68 million. It is projected to garner US$ 5,961.23 million by 2030 to expand at 5.9% CAGR during 2022-2030.

By end user, the North America rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held 47.2% share of North America rapid test kit market in 2022, amassing US$ 3,239.21 million. It is projected to garner US$ 4,918.87 million by 2030 to expand at 5.4% CAGR during 2022-2030.

Based on country, the North America rapid test kit market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.4% share of North America rapid test kit market in 2022. It was assessed at US$ 5,729.08 million in 2022 and is likely to hit US$ 8,814.48 million by 2030, exhibiting a CAGR of 5.5% during 2022-2030.

Key players operating in the North America rapid test kit market are F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, SD Biosensor Inc, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc, among others.

In October 2022, Roche announced the launch of the Anti-PRAME (EPR 20330) Rabbit Monoclonal Primary Antibody for identifying PRAME protein expression in tissue samples of patients suspected of having melanoma. The newly launched antibody is fully automated on the full line of Roche BenchMark IHC/ISH instruments. It is validated to be used with OptiView DAB IHC Detection, ultraView Universal DAB Detection, and ultraView Universal Alkaline Phosphatase Red Detection Kits.

In November 2022, OraSure Technologies has launched its InteliSwab COVID-19 Rapid Test, available on Amazon’s online store in the US. The test is simple and easy to use, requiring only a swab of the lower nostrils and a swirl of a pre-measured solution. It was recently selected for nationwide school testing.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America rapid test kit market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America rapid test kit market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America rapid test kit market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Rapid Test Kits Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market – North America Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
6. North America Rapid Test Kits Market Analysis – by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Rapid Test Kits Market Analysis – by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Rapid Test Kits Market Analysis – by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Rapid Test Kits Market Analysis – by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application – Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Rapid Test Kits Market Analysis – by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11. North America Rapid Test Kits Market – Country Analysis
11.1 North America: Rapid Test Kits Market
11.1.1 North America: Rapid Test Kits Market – Revenue and Forecast Analysis – by Country
11.1.1.1 United States
11.1.1.1.1 Overview
11.1.1.2 United States: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 United States: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 United States: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 United States: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 United States: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 United States: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 United States: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 Canada
11.1.1.3.1 Overview
11.1.1.4 Canada: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Canada: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 Canada: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 Canada: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 Canada: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 Canada: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 Canada: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.5.1 Overview
11.1.1.6 Mexico
11.1.1.6.1 Mexico: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 Mexico: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 Mexico: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 Mexico: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 Mexico: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 Mexico: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Fujirebio Europe NV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 bioMerieux SA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Cepheid
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QIAGEN NV
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 OraSure Technologies Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Denka Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Abbott Laboratories
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Trinity Biotech Plc
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 SD Biosensor Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Beckman Coulter Inc
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
14. Appendix
14.1 About The the Reporting Teams

LIST OF TABLES

Table 1. Rapid Test Kits Market Segmentation
Table 2. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Table 3. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 4. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 5. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 6. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 7. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 8. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 9. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 10. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 11. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 12. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 13. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 14. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 16. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Product
Table 17. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Technology
Table 18. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Application
Table 19. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by Infectious Disease Testing
Table 20. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 21. Recent Inorganic Growth Strategies in the Rapid Test Kit Market
Table 22. Recent Organic Growth Strategies in the Rapid Test Kit Market

LIST OF FIGURES

Figure 1. Rapid Test Kits Market Segmentation, By Country
Figure 2. Rapid Test Kits Market: Key Industry Dynamics
Figure 3. Rapid Test Kits Market: Impact Analysis of Drivers and Restraints
Figure 4. Rapid Test Kits Market Revenue (US$ Mn), 2020 – 2030
Figure 5. Rapid Test Kits Market Share (%) – by Type (2022 and 2030)
Figure 6. Rapid Antigen Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Rapid Antibody Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Rapid Test Kits Market Share (%) – by Product (2022 and 2030)
Figure 10. Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Professional Rapid Testing Kit: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Rapid Test Kits Market Share (%) – by Technology (2022 and 2030)
Figure 13. Lateral Flow Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solid Phase: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Agglutination: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Immunospot Assay: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cellular-Component Based: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Rapid Test Kits Market Share (%) – by Application (2022 and 2030)
Figure 19. Blood Glucose Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Infectious Disease Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Cardiometabolic Testing: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pregnancy and Fertility: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Rapid Test Kits Market Share (%) – by End User (2022 and 2030)
Figure 25. Hospital and Clinics: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diagnostic Centers: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Home-Care: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Rapid Test Kits Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America: Rapid Test Kits Market, by Key Country – Revenue (2022) (US$ Million)
Figure 30. North America: Rapid Test Kits Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 31. United States: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Canada: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Mexico: Rapid Test Kits Market – Revenue and Forecast to 2030(US$ Million)
Figure 34. Growth Strategies in the Rapid Test Kit Market

The List of Companies – North America Rapid Test Kit Market

1. F. Hoffmann-La Roche Ltd
2. Becton Dickinson and Co
3. ARKRAY Inc
4. Fujirebio Europe NV
5. bioMerieux SA
6. Cepheid
7. Meril Life Sciences Pvt Ltd
8. QIAGEN NV
9. OraSure Technologies Inc
10. Guangzhou Wondfo Biotech Co Ltd
11. Denka Co Ltd
12. Abbott Laboratories
13. Trinity Biotech Plc
14. SD Biosensor Inc
15. Bio-Rad Laboratories Inc
16. Hologic Inc
17. DiaSorin SpA
18. Beckman Coulter Inc

Reviews

There are no reviews yet.

Be the first to review “North America Rapid Test Kit Market Forecast to 2030”